3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
145
Lymphoma, Follicular
41
Lymphoma, Large B-Cell, Diffuse
36
Lymphoma, B-Cell, Marginal Zone
24
Recurrence
17
Lymphoma, Mantle-Cell
17
Lymphoma
16
Neoplasms, Plasma Cell
15
Lymphoma, Non-Hodgkin
15
Leukemia, Lymphocytic, Chronic, B-Cell
11
Neoplasms
9
Lymphoma, B-Cell
8
Smoldering Multiple Myeloma
7
Burkitt Lymphoma
5
Neoplasm, Residual
4
Leukemia, Plasma Cell
4
Waldenstrom Macroglobulinemia
3
Myelodysplastic Syndromes
3
Lymphoma, T-Cell, Peripheral
3
Lymphoma, T-Cell, Cutaneous
3
Plasmacytoma
2
Pancreatic Neoplasms
2
Neuroblastoma
2
Lymphoma, T-Cell
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Myeloid, Acute
2
Leukemia
2
Hodgkin Disease
2
Hematologic Diseases
2
Urinary Bladder Neoplasms
1
Interventions
Cyclophosphamide
11
Dexamethasone
10
Cytarabine
10
Vincristine
8
Methotrexate
7
merphos
5
Mercaptopurine
5
Doxorubicin
5
venetoclax
4
pegaspargase
4
dexamethasone acetate
4
dexamethasone 21-phosphate
4
blinatumomab
4
azathiopurine
4
auricularum
4
Specimen Handling
4
Prednisone
4
Leucovorin
4
Inotuzumab Ozogamicin
4
Calcium Dobesilate
4
prednylidene
3
deltacortene
3
Thioguanine
3
N,N-dicyclohexyl-isoborneol-10-sulfonamide
3
Methylprednisolone
3
Asparaginase
3
calaspargase pegol
2
asparaginase erwinia chrysanthemi recombinant
2
Spinal Puncture
2
Rituximab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
×
Lenalidomide
×
1 year
×
Clear all
No trials found.